Severe Acute Thrombocytopenia After Treatment with Tirofiban: A Case Series Approach
Glycoprotein IIb/IIIa inhibitors are an adjuvant therapy for the treatment of patients with acute coronary syndromes. The main adverse reactions are bleeding and thrombocytopenia in 1–2% of cases. A 66-year-old woman arrived at the emergency department with ST-elevation MI. The catheterisation lab w...
Saved in:
| Main Authors: | Gian-Manuel Jiménez-Rodríguez, Patricia Carmona-Levario, José-Alberto Ayón-Martínez, Aleksandra Gasecka, Luis Eduardo Juárez-Orozco, Antonio Reyes-Ortega, Patricia Espinosa-González, Gyna Alejandra Altamirano-Solorzano, Guering Eid-Lidt |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2023-04-01
|
| Series: | Interventional Cardiology: Reviews, Research, Resources |
| Online Access: | https://www.icrjournal.com/articleindex/icr.2022.23 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SAFETY OF TIROFIBAN FOR PATIENTS WITH ACUTE ISCHEMIC STROKE IN ROUTINE CLINICAL PRACTICE
by: Yan-Jun Zhang, et al.
Published: (2014-04-01) -
Tirofiban Combination Therapy for Acute Ischemic Stroke: A Systematic Review and Meta‐Analysis
by: Abdullah Bin Kamran, et al.
Published: (2025-06-01) -
Evaluation of safety and efficacy of Tirofiban injection for treating acute ischemic stroke beyond standard time window
by: Qian Yang, et al.
Published: (2025-07-01) -
Safety Profile of Intra-Arterial Tirofiban as a Rescue Therapy during Mechanical Thrombectomy in Acute Ischemic Stroke
by: Karthikeyan Muthugounder Athiyappan, et al.
Published: (2024-04-01) -
Effect of Intravenous Tirofiban Versus Placebo on Excellent Outcome in Patients With Acute Ischemic Stroke: The Multicenter, Randomized INSTANT Trial Protocol
by: Fan Zhang, et al.
Published: (2025-07-01)